LARIMAR THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
LARIMAR THERAPEUTICS, INC. (LRMR) reported Basic Shares Outstanding (Weighted Average) of 78.32 million shares for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2025-11-05
- LARIMAR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 78.32M shares, a 22.75% increase year-over-year.
- LARIMAR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 64.03M shares, a 0.35% increase year-over-year.
- LARIMAR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 63.96M shares, a 19.44% increase year-over-year.
- LARIMAR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2024-12-31 was 63.83M shares, a 45.37% increase year-over-year.
- LARIMAR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 61.26M shares, a 39.53% increase from fiscal 2023.
- LARIMAR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 43.90M shares, a 70.41% increase from fiscal 2022.
- LARIMAR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 25.76M shares, a 50.09% increase from fiscal 2021.
- LARIMAR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 17.16M shares, a 44.44% increase from fiscal 2020.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2025-09-30 | 78.32M shares 10-Q · filed 2025-11-05 | 71.18M shares derived: average of 2 quarters · filed 2025-11-05 | 68.82M shares 10-Q · filed 2025-11-05 | 67.54M shares derived: average of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 64.03M shares 10-Q · filed 2025-08-14 | 64.00M shares 10-Q · filed 2025-08-14 | 63.94M shares derived: average of 3 quarters · filed 2025-08-14 | 63.91M shares derived: average of 4 quarters · filed 2025-11-05 |
| 2025-03-31 | 63.96M shares 10-Q · filed 2025-04-30 | 63.89M shares derived: average of 2 quarters · filed 2025-04-30 | 63.87M shares derived: average of 3 quarters · filed 2025-11-05 | 63.85M shares derived: average of 4 quarters · filed 2025-11-05 |
| 2024-12-31 | 63.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 63.82M shares derived: average of 2 quarters · filed 2025-11-05 | 63.81M shares derived: average of 3 quarters · filed 2025-11-05 | 61.26M shares 10-K · filed 2025-03-24 |
| 2024-09-30 | 63.81M shares 10-Q · filed 2025-11-05 | 63.80M shares derived: average of 2 quarters · filed 2025-11-05 | 60.40M shares 10-Q · filed 2025-11-05 | 56.27M shares derived: average of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | 63.80M shares 10-Q · filed 2025-08-14 | 58.68M shares 10-Q · filed 2025-08-14 | 53.75M shares derived: average of 3 quarters · filed 2025-08-14 | 51.29M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 53.55M shares 10-Q · filed 2025-04-30 | 48.73M shares derived: average of 2 quarters · filed 2025-04-30 | 47.12M shares derived: average of 3 quarters · filed 2025-04-30 | 46.32M shares derived: average of 4 quarters · filed 2025-04-30 |
| 2023-12-31 | 43.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 43.90M shares derived: average of 2 quarters · filed 2025-03-24 | 43.90M shares derived: average of 3 quarters · filed 2025-03-24 | 43.90M shares 10-K · filed 2025-03-24 |
| 2023-09-30 | 43.90M shares 10-Q · filed 2024-10-30 | 43.90M shares derived: average of 2 quarters · filed 2024-10-30 | 43.90M shares 10-Q · filed 2024-10-30 | 43.95M shares derived: average of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | 43.90M shares 10-Q · filed 2024-08-08 | 43.90M shares 10-Q · filed 2024-08-08 | 43.96M shares derived: average of 3 quarters · filed 2024-08-08 | 38.53M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 43.90M shares 10-Q · filed 2024-05-09 | 44.00M shares derived: average of 2 quarters · filed 2024-05-09 | 36.74M shares derived: average of 3 quarters · filed 2024-05-09 | 32.14M shares derived: average of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 44.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 33.16M shares derived: average of 2 quarters · filed 2024-03-14 | 28.22M shares derived: average of 3 quarters · filed 2024-03-14 | 25.76M shares 10-K · filed 2024-03-14 |
| 2022-09-30 | 22.23M shares 10-Q · filed 2023-11-14 | 20.28M shares derived: average of 2 quarters · filed 2023-11-14 | 19.65M shares 10-Q · filed 2023-11-14 | 19.31M shares derived: average of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | 18.34M shares 10-Q · filed 2023-08-10 | 18.34M shares 10-Q · filed 2023-08-10 | 18.34M shares derived: average of 3 quarters · filed 2023-08-10 | 18.33M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 18.34M shares 10-Q · filed 2023-05-15 | 18.35M shares derived: average of 2 quarters · filed 2023-05-15 | 18.33M shares derived: average of 3 quarters · filed 2023-05-15 | 17.74M shares derived: average of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 18.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | 18.32M shares derived: average of 2 quarters · filed 2023-03-14 | 17.55M shares derived: average of 3 quarters · filed 2023-03-14 | 17.16M shares 10-K · filed 2023-03-14 |
| 2021-09-30 | 18.29M shares 10-Q · filed 2022-11-10 | 17.14M shares derived: average of 2 quarters · filed 2022-11-10 | 16.77M shares 10-Q · filed 2022-11-10 | 16.57M shares derived: average of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | 16.00M shares 10-Q · filed 2022-08-11 | 16.00M shares 10-Q · filed 2022-08-11 | 16.00M shares derived: average of 3 quarters · filed 2022-08-11 | 16.00M shares derived: average of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | 16.00M shares 10-Q · filed 2022-05-12 | 16.01M shares derived: average of 2 quarters · filed 2022-05-12 | 16.00M shares derived: average of 3 quarters · filed 2022-05-12 | 14.34M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | 16.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | 16.00M shares derived: average of 2 quarters · filed 2022-03-25 | 13.79M shares derived: average of 3 quarters · filed 2022-03-25 | 11.88M shares 10-K · filed 2022-03-25 |
| 2020-09-30 | 15.98M shares 10-Q · filed 2021-11-12 | 12.68M shares derived: average of 2 quarters · filed 2021-11-12 | 10.51M shares 10-Q · filed 2021-11-12 | |
| 2020-06-30 | 9.38M shares 10-Q · filed 2021-08-12 | 7.74M shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |